尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the detailed record of transactions filed by Fountain Tamara. Director active across 2 companies, notably Sight Sciences, Inc.. Cumulatively, 10 disclosures have been published. Split: 0 buy · 1 sell. Total volume traded: €165k. Activity tracked since 8 January 2023. The latest transaction was disclosed on 5 June 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Fountain Tamara is a declarant and serves as a Director at RxSight, Inc. and Sight Sciences, Inc. She has 10 filings in total, and, across the sampled recent filings, the reported sell volume is EUR 164925, with no buys, over the period from 2023-01-10 to 2026-06-18. The modal transaction nature is Attribution.